Detrusor Overactivity Clinical Trial
Official title:
Prevalence of Urodynamic Stress Incontinence and/or Detrusor Overactivity in Women With Cystocele and the Changes of Continence Function After Cystocele Repair
The changes of lower urinary tract function after cystocele repair are important for perioperative consultation and management. Thus, the aim of this retrospective study was to evaluate the prevalence of urodynamic stress incontinence and/or detrusor overactivity in women with ≥ stage II cystocele and the changes of incontinence function after cystocele repair.
Between November 2010 and October 2020, all women with ≥ stage II cystocele who visited the urogynecological department of a medical center for cystocele repair were reviewed. Those women who had complete data of preoperative and postoperative 3-month follow-up urodynamic data were excluded from this study. Urodynamic stress incontinence was diagnosed by the finding of involuntary leakage during filling cystometry or stress urethral pressure profile, associated with increased intra-abdominal pressure, in the absence of a detrusor contraction. Detrusor overactivity was defined as the occurrence of involuntary detrusor contractions during filling cytometry. STATA software was used for statistical analysis. Chi2 test, univariate and multivariable logistic regression tests were used for statistical analysis as appropriate. A p < 0.05 was considered as statistically significant. ;
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT04543552 -
A Comparative Analysis of Portable Bladder Scanner to Determine Age/ Volume Specific Accuracy in 0-6 Years of Children
|
||
Not yet recruiting |
NCT04693897 -
Effect of beta3-adrenoceptor Agonist on Patients With Overactive Bladder and as a Urinary Biomarker
|
||
Enrolling by invitation |
NCT00822913 -
Botulinum A Toxin in Patients With Parkinson's Disease
|
Phase 4 | |
Terminated |
NCT00373789 -
Refractory Urge Incontinence and Botox Injections
|
Phase 3 | |
Completed |
NCT01093534 -
Study of 2 Doses of Solifenacin Succinate in Female Subjects With Overactive Bladder.
|
Phase 4 | |
Completed |
NCT01003457 -
Ultrasonographic Bladder Wall Thickness and Different Forms of Detrusor Overactivity
|
N/A | |
Terminated |
NCT01023269 -
Efficacy Study of Pudendal Neuromodulation for the Treatment of Neurogenic Overactive Bladder
|
N/A | |
Not yet recruiting |
NCT05572918 -
Developing a Simple Test to Diagnose Overactive Bladder
|
||
Completed |
NCT01850706 -
UNGF Assessment in Patients With Detrusor Overactivity Undergoing Sacral Neuromodulation
|
N/A | |
Completed |
NCT00478881 -
A Study To Assess If 10 mg Vardenafil (BAY38-9456) Taken Twice Daily For 6 Weeks Has An Effect On Bladder Function
|
Phase 2 | |
Completed |
NCT00678795 -
A Parallel Group Study to Compare Sativex® With Placebo in the Treatment of Detrusor Overactivity in Patients With Multiple Sclerosis
|
Phase 3 |